For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...
Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsir...
Singapore: Daiichi Sankyo has announced a new five-year business plan, which will span from April 1, 2013 through March ...
Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...
Singapore: The European Commission (EC) has granted European market authorization for the medicinal product teduglutide ...
Singapore:Â In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an a...
The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month...
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...
Daiichi Sankyo Inc., the US subsidiary of Daiichi Sankyo Company Ltd, will merge with its US-based sister company, Asubi...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore:Â Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical t...
Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the ...
Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine bus...
Singapore:Â Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision L...
Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in ...
Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 8...
With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connectin...
Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief ...
Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating M...
Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth bet...
Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial o...
Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included...
Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the g...
